High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
Abstract Due to the therapy resistance and frequent metastasis, pancreatic ductal adenocarcinoma(PDAC) remains one of the most malignant carcinoma. WNT7A, an important ligand of Wnt/β-catenin signaling pathways, has a controversial role in tumor development. The role of WNT7A in PDAC remains unclear...
Guardado en:
Autores principales: | Dong-jin Wu, Yong-sheng Jiang, Rui-zhe He, Ling-ye Tao, Min-wei Yang, Xue-liang Fu, Jiang-yu Yang, Kun Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b177089439884fc18495fe7a563e2abb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
por: Shin-Heng Chiou, et al.
Publicado: (2018) -
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: Iranzu González-Borja, et al.
Publicado: (2021) -
Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
por: Hongjin Wu, et al.
Publicado: (2021) -
Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
por: Monika Kapszewicz, et al.
Publicado: (2021) -
The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma
por: Ricki T. Krog, et al.
Publicado: (2021)